Mode
Text Size
Log in / Sign up

Intraosseous route for out-of-hospital cardiac arrest linked to lower outcomes than intravenous accessUsing a bone needle instead of a vein line lowers survival chances for cardiac arrest patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider intravenous over intraosseous access for out-of-hospital cardiac arrest when feasible, based on associated lower outcomes.

This publication is a systematic review and GRADE meta-analysis of observational studies. The population consisted of 245,132 patients experiencing out-of-hospital cardiac arrest. The setting was the out-of-hospital environment. The intervention was intraosseous (IO) vascular access, and the comparator was intravenous (IV) vascular access. The review synthesized data on multiple primary outcomes, including return of spontaneous circulation, sustained return of spontaneous circulation, favorable neurological outcomes at hospital discharge, survival at hospital arrival, survival at hospital discharge, and short-term survival.

The primary outcome results showed that the IO route was associated with a significantly lower return of spontaneous circulation compared to the IV route, with a relative risk (RR) of 0.77 (95% CI: 0.71-0.83, P < .00001; I2 = 84%). For sustained return of spontaneous circulation, the IO route had an RR of 0.87 (95% CI: 0.77-0.97, P = .02; I2 = 53%). Favorable neurological outcomes at hospital discharge were lower with the IO route, with an RR of 0.58 (95% CI: 0.45-0.73, P < .00001; I2 = 81%). Survival at hospital arrival was lower with the IO route, with an RR of 0.79 (95% CI: 0.72-0.86, P < .00001; I2 = 49%). Survival at hospital discharge was lower with the IO route, with an RR of 0.59 (95% CI: 0.45-0.78, P < .0002; I2 = 95%). Short-term survival was lower with the IO route, with an RR of 0.52 (95% CI: 0.32-0.86, P = .010; I2 = 72%).

The review did not report key secondary outcomes. Safety and tolerability findings were not reported, including adverse events, serious adverse events, and discontinuations. The certainty of the evidence was not reported. The review did not compare these results to prior landmark studies in this therapeutic area, as no specific prior studies were cited in the input.

Key methodological limitations and potential biases were not reported in the input. The review is a synthesis of observational data, and causality cannot be inferred. The high I2 values indicate substantial heterogeneity across studies, which may affect the reliability of the pooled estimates.

Clinical implications from the practice relevance note state that the IV route should be preferred in emergency resuscitation protocols when feasible. This suggests that, based on the observed associations, clinicians might prioritize IV access over IO access during out-of-hospital cardiac arrest resuscitation when both options are available.

Key questions remain unanswered. The review did not report on specific patient subgroups, such as those with difficult IV access, or on the impact of different IO insertion techniques. The mechanisms behind the observed associations are not elucidated, and the review did not explore potential confounders or effect modifiers. Future research is needed to address these gaps and to clarify the role of IO access in specific clinical scenarios.

When a person stops breathing or has a heart attack outside the hospital, doctors rush to give them medicine to restart their heart. Usually, doctors try to find a vein in the arm or neck to put the medicine in. Sometimes, they cannot find a vein quickly enough. In those cases, they might use a special needle that goes into the bone near the hip or knee. This is called the intraosseous or IO route. A new big study looked at how well this method works compared to using a normal vein, which is called the intravenous or IV route.

This study looked at data from more than 245,000 patients. It compared people who got medicine through the bone with those who got it through a vein. The results were clear and important for emergency teams everywhere. The team found that using the bone needle was linked to lower chances of the heart starting to beat again on its own. This is a very serious problem because getting the heart to beat again is the first step to saving a life.

The study also looked at how long the heart stayed beating and how well the brain worked after the patient left the hospital. People treated with the bone needle had much lower chances of having a good brain outcome. In fact, the chance of a good brain result was about 42 percent lower for those who got the medicine in the bone. This means the bone method is not as good as the vein method for helping the brain recover.

Survival rates were also much lower for patients treated with the bone needle. The chance of surviving until they left the hospital was about 41 percent lower. The chance of surviving for a short time after the event was also much lower. These numbers show that the bone needle does not work as well as the standard vein line. The study showed that the bone method is significantly worse for these important health results.

Doctors say that if you can find a vein, you should use it. The bone needle is a backup plan when a vein cannot be found quickly. Emergency teams need to know that using the bone needle might hurt the patient's chances of survival. They should try very hard to find a vein first. This study helps doctors make better choices to save lives during these very scary emergencies.

What this means for you:
Doctors should use a vein line for medicine instead of a bone needle to give patients the best chance of survival.

Study Details

Study typeMeta analysis
Sample sizen = 245,132
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Out-of-hospital cardiac arrest, which poses a severe challenge due to high mortality rates in emergency cases, warrants the need for effective resuscitation measures. This meta-analysis evaluated survival outcomes for intraosseous (IO) versus intravenous (IV) drug administration. METHODS: Electronic databases, including PubMed, Cochrane Central, and ScienceDirect, were searched from inception until September 2024. Risk ratios (RRs) and 95 % confidence intervals (CIs) were pooled using Review Manager version 5.4.1 under a random-effects model for dichotomous outcomes. The quality of the studies was evaluated using the Cochrane Risk of Bias tool (RoB 2.0) and Newcastle-Ottawa Scale. Certainty of evidence was assessed through the grading of recommendations, assessment, development, and evaluations assessment. RESULTS: The quantitative analysis included 18 studies comprising a total sample size of 245,132 patients. IO route was associated with a significantly lower return of spontaneous circulation (RR = 0.77, 95% CI: [0.71-0.83]; P < .00001; I2 = 84%), sustained return of spontaneous circulation (RR = 0.87, 95% CI: [0.77-0.97]; P = .02; I2 = 53%) and favorable neurological outcomes at hospital discharge (RR = 0.58, 95% CI: [0.45-0.73]; P < .00001; I2 = 81%) compared to IV route. It also showed a significantly lower survival at hospital arrival (RR = 0.79; 95% CI: [0.72-0.86]; P < .00001; I2 = 49%) and at hospital discharge (RR = 0.59; 95% CI: [0.45-0.78]; P < .0002; I2 = 95%) and short-term survival (RR = 0.52; 95% CI: [0.32-0.86]; P = .010; I2 = 72%). No publication bias was detected. CONCLUSION: This meta-analysis showed that IV access is superior to IO in terms of favorable neurological outcomes and survival to hospital arrival and discharge in out-of-hospital cardiac arrest patients. This suggests that when feasible, the IV route should be preferred in emergency resuscitation protocols.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.